Ancillary Study to Protocol 20060104
NCT00439894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2008-03-21
Summary
Ancillary study to the Etanercept protocol 20060104. Subjects have been asked to provide additional blood samples for further assessment.
Conditions
Interventions
- PROCEDURE
-
Blood draw
blood draw at baseline, week 12 and week 24
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
MD · Amgen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2007-08-31
- Completion
- 2007-10-31
More Related Trials
-
A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
NCT00713544 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis
NCT00443950 ·Status: COMPLETED ·Phase: PHASE3
-
16.0040 Ankylosing Spondylitis Study
NCT00356356 ·Status: COMPLETED ·Phase: PHASE3
-
Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study
NCT00522184 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis
NCT00913458 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Efficacy and Safety of Etanercept
NCT00546533 ·Status: COMPLETED ·Phase: PHASE4
-
Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy
NCT00848354 ·Status: COMPLETED ·Phase: PHASE4
-
Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012
NCT00356590 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission
NCT02373813 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials
NCT00357903 ·Status: COMPLETED ·Phase: PHASE3
-
Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening
NCT01578850 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Safety of Enbrel (Etanercept)
NCT00683384 ·Status: COMPLETED
-
Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept
NCT00459706 ·Status: COMPLETED ·Phase: PHASE3
-
Enbrel Liquid Immunogenicity Protocol
NCT00249041 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
NCT01783015 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
NCT01411215 ·Status: TERMINATED
-
The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept
NCT00034060 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects
NCT02378506 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects
NCT00252668 ·Status: COMPLETED ·Phase: PHASE4
-
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
NCT01313208 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
NCT00245934 ·Status: COMPLETED
-
This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.
NCT04267614 ·Status: COMPLETED
-
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
NCT04428424 ·Status: COMPLETED
-
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
NCT00293722 ·Status: COMPLETED
-
A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis
NCT00783536 ·Status: WITHDRAWN ·Phase: PHASE4